Humoral factors in serum as predictors of therapeutic response to tumor necrosis factor inhibitors in rheumatoid arthritis.

Autor: Saito K; Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan., Yamamoto S; Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan., Kamata Y; Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan., Nagashima T; Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan., Sato T; Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan., Minota S; Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan., Sato K; Division of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan.

Publikováno v: International journal of rheumatic diseases [Int J Rheum Dis] 2024 Nov; Vol. 27 (11), pp. e15413.

Biomarker combination predicting imminent relapse after discontinuation of biological drugs in patients with rheumatoid arthritis in remission.

Autor: Sakashita E; Department of Biochemistry, Jichi Medical University School of Medicine, Tochigi, Japan., Nagatani K; Department of Medicine, Division of Rheumatology and Clinical Immunology, Jichi Medical University School of Medicine, Tochigi, Japan., Endo H; Department of Biochemistry, Jichi Medical University School of Medicine, Tochigi, Japan., Minota S; Department of Medicine, Division of Rheumatology and Clinical Immunology, Jichi Medical University School of Medicine, Tochigi, Japan.

Publikováno v: PloS one [PLoS One] 2024 Mar 21; Vol. 19 (3), pp. e0299450. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).

Bronchiectasis is as crucial as interstitial lung disease in the severe pneumonia that occurs during treatment with biologic DMARDs in rheumatoid arthritis: a retrospective cohort study in a single facility.

Autor: Honne K; Division of Rheumatology and Clinical Immunology, Jichi Medical University, Shimotsuke, Tochigi, 329-0498, Japan. honnek@jichi.ac.jp., Bando M; Division of Pulmonary Medicine, Jichi Medical University, Shimotsuke, Tochigi, 329-0498, Japan., Mieno MN; Center for Information, Jichi Medical University, Shimotsuke, Tochigi, 329-0498, Japan., Iwamoto M; Division of Rheumatology and Clinical Immunology, Jichi Medical University, Shimotsuke, Tochigi, 329-0498, Japan., Minota S; Division of Rheumatology and Clinical Immunology, Jichi Medical University, Shimotsuke, Tochigi, 329-0498, Japan.

Publikováno v: Rheumatology international [Rheumatol Int] 2022 Aug; Vol. 42 (8), pp. 1341-1346. Date of Electronic Publication: 2021 Jul 12.

A novel multi-biomarker combination predicting relapse from long-term remission after discontinuation of biological drugs in rheumatoid arthritis.

Autor: Nagatani K; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Jichi Medical University School of Medicine, Tochigi, Japan., Sakashita E; Department of Biochemistry, Jichi Medical University School of Medicine, Tochigi, Japan., Endo H; Department of Biochemistry, Jichi Medical University School of Medicine, Tochigi, Japan., Minota S; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Jichi Medical University School of Medicine, Tochigi, Japan. sminota@jichi.ac.jp.

Publikováno v: Scientific reports [Sci Rep] 2021 Oct 21; Vol. 11 (1), pp. 20771. Date of Electronic Publication: 2021 Oct 21.

Clinical characteristics of lupus enteritis in Japanese patients: the large intestine-dominant type has features of intestinal pseudo-obstruction.

Autor: Maruyama, A., Nagashima, T., Iwamoto, M., Minota, S.

Publikováno v: Lupus; Sep2018, Vol. 27 Issue 10, p1661-1669, 9p, 2 Black and White Photographs, 2 Charts